Evidence-Based Medicine Guidelines
Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD) is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Selective Serotonin Re-uptake Inhibitors (SSRIs) Versus Placebo for Obsessive Compulsive Disorder (OCD)." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455960/all/Selective_serotonin_re_uptake_inhibitors__SSRIs__versus_placebo_for_obsessive_compulsive_disorder__OCD_.
Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455960/all/Selective_serotonin_re_uptake_inhibitors__SSRIs__versus_placebo_for_obsessive_compulsive_disorder__OCD_. Accessed April 1, 2023.
Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455960/all/Selective_serotonin_re_uptake_inhibitors__SSRIs__versus_placebo_for_obsessive_compulsive_disorder__OCD_
Selective Serotonin Re-uptake Inhibitors (SSRIs) Versus Placebo for Obsessive Compulsive Disorder (OCD) [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 April 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455960/all/Selective_serotonin_re_uptake_inhibitors__SSRIs__versus_placebo_for_obsessive_compulsive_disorder__OCD_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
ID - 455960
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455960/all/Selective_serotonin_re_uptake_inhibitors__SSRIs__versus_placebo_for_obsessive_compulsive_disorder__OCD_
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
